Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Edoxaban in Non-valvular Atrial Fibrillation with Severe Renal Impairment
jRCT2080221674Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of edoxaban in Atrial fibrillation (AFib) (3 arms), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCT2080221674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221674.